Oct 14, 2026 08:30AM
Oct 14, 2026 08:30AM
Oct 8, 2026 07:00AM
Oct 7, 2026 08:30AM
Oct 7, 2026 08:30AM
Sep 25, 2026 06:47AM
Sep 18, 2026 06:43AM Ultragenyx Pharma (RARE) PT Raised to $39 at Canaccord
Sep 18, 2026 05:17AM
Sep 17, 2026 03:48PM
Sep 17, 2026 03:48PM
Sep 17, 2026 02:29PM
Sep 2, 2026 04:01PM
Sep 2, 2026 04:01PM
Sep 1, 2026 04:06PM Ultragenyx publishes 96-week phase 3 data for GSDIa gene therapy
Sep 1, 2026 04:05PM
Aug 20, 2026 06:56AM
Aug 20, 2026 06:50AM
Aug 20, 2026 05:04AM
Aug 19, 2026 05:21PM
Aug 19, 2026 05:21PM
Aug 4, 2026 04:05PM Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update
Jun 23, 2026 08:00AM
Jun 23, 2026 08:00AM
May 5, 2026 04:01PM
Apr 2, 2026 12:00PM
Apr 2, 2026 10:46AM
Apr 2, 2026 08:31AM
Apr 2, 2026 08:30AM Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
Mar 30, 2026 08:32AM
Mar 30, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 18, 2026 06:44AM
Feb 12, 2026 04:01PM
Feb 3, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
Jan 30, 2026 08:31AM
Jan 30, 2026 08:30AM
Jan 12, 2026 07:31AM
Jan 12, 2026 07:30AM
Dec 30, 2025 04:06PM
Dec 30, 2025 04:05PM
Dec 30, 2025 04:58AM Ultragenyx Pharma (RARE) PT Lowered to $45 at Wells Fargo
Dec 30, 2025 02:03AM
Dec 29, 2025 01:50PM
Dec 29, 2025 08:30AM
Dec 29, 2025 08:30AM
Nov 4, 2025 04:05PM
Oct 30, 2025 08:00AM
Sep 8, 2025 04:05PM Ultragenyx reports positive 96-week data for GSDIa gene therapy DTX401
Sep 8, 2025 04:05PM

334,267 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All